Onivyde pegylated liposomal (previously known as Onivyde) Uniunea Europeană - maghiară - EMA (European Medicines Agency)

onivyde pegylated liposomal (previously known as onivyde)

les laboratoires servier - irinotecan anhydrous free-base - hasnyálmirigy-daganatok - daganatellenes szerek - kezelés a metasztatikus adenocarcinoma a hasnyálmirigy, együtt 5 fluorouracil (5-fu) és leucovorin (lv), a felnőtt betegek gemcitabin követően fejlődött alapú terápia.

Imfinzi Uniunea Europeană - maghiară - EMA (European Medicines Agency)

imfinzi

astrazeneca ab - durvalumab - karcinóma, nem kissejtes tüdő - daganatellenes szerek - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Kimmtrak Uniunea Europeană - maghiară - EMA (European Medicines Agency)

kimmtrak

immunocore ireland limited - tebentafusp - uveal neoplasms - daganatellenes szerek - kimmtrak is indicated as monotherapy for the treatment of human leukocyte antigen (hla)-a*02:01-positive adult patients with unresectable or metastatic uveal melanoma.